Aptose Biosciences Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Aptose Biosciences Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2017 to Q2 2024.
  • Aptose Biosciences Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 18.1M shares, a 184% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 18.1M +11.7M +184% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 15.7M -77.3M -83.1% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 7.94M +1.78M +29% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 7.54M -84.8M -91.8% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 6.38M -85.9M -93.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 93M +776K +0.84% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 6.16M -86.1M -93.3% Dec 31, 2022 10-K 2024-03-26
Q3 2022 92.3M +3.35M +3.76% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 92.3M +3.31M +3.72% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 92.2M +3.31M +3.72% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 92.2M +3.33M +3.75% Dec 31, 2021 10-K 2023-03-24
Q3 2021 88.9M +87K +0.1% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 88.9M +12.7M +16.6% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 88.9M +12.7M +16.6% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 88.9M +12.8M +16.8% Dec 31, 2020 10-K 2022-03-22
Q3 2020 88.9M +33.4M +60.2% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 76.3M +20.9M +37.6% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 76.3M -41.4B Mar 31, 2020 10-Q 2020-05-05
Q4 2019 76.1M +37.9M +99.4% Dec 31, 2019 10-K 2021-03-23
Q3 2019 55.5M +20.5M +58.5% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 55.4M +21M +61.1% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 41.5B* +41.5B Mar 31, 2019 10-Q 2019-05-07
Q4 2018 38.2M +10.7M +38.8% Dec 31, 2018 10-K 2020-03-10
Q3 2018 35M Sep 30, 2018 8-K 2019-03-12
Q2 2018 34.4M Jun 30, 2018 8-K 2019-03-12
Q1 2018 30.7M Mar 31, 2018 8-K 2019-03-12
Q4 2017 27.5M Dec 31, 2017 8-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.